During the past decade, Seattle CHildrens Research Institute conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 15 clinical trials were completed, i.e. on average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 13 clinical trials were completed. i.e. 65% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seattle CHildrens Research Institute" #1 sponsor was "Seattle Children's Hospital" with 25 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Rhythm Pharmaceuticals, Inc." with 3 trials sponsored, "Marinus Pharmaceuticals" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle CHildrens Research Institute" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 6 trials as a collaborator, "University of Washington" with 4 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 3 trials as a collaborator, "Seattle Children's Hospital" with 3 trials as a collaborator and "Baylor College of Medicine" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Seattle CHildrens Research Institute" are "Physical Activity" (7 trials), "Autism Spectrum Disorder" (4 trials), "Cerebral Palsy" (4 trials), "Obesity" (3 trials) and "ADHD" (2 trials). Many other conditions were trialed in "Seattle CHildrens Research Institute" in a lesser frequency.

Most popular intervention types in "Seattle CHildrens Research Institute" are "Drug" (29 trials), "Behavioral" (26 trials), "Other" (8 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ramucirumab" (3 trials), "Setmelanotide" (3 trials), "Cyclophosphamide" (2 trials) and "Galcanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Seattle CHildrens Research Institute" are 61 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Seattle CHildrens Research Institute". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 34 completed trials in Seattle CHildrens Research Institute, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Seattle CHildrens Research Institute, 7 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 31 trials that are defined as “Not Applicable".